BioSpace News Archive

Business

Quit Smoking Without Nicotine: Pharmathen Hellas S.A. to Distribute Acetium Lozenge in Greece

The first deliveries of the product will be in early 2018.

January 30, 2018
·
2 min read
Business

Helsinn and the Scientific Centre of Monaco Sign Collaboration Agreement

ccRCC is diagnosed in over 200,000 patients worldwide each year and the number of people affected continues to increase.

January 30, 2018
·
3 min read
Biotech Bay

CymaBay Announces Proposed Public Offering of Common Stock

CymaBay anticipates using the net proceeds from the offering to fund ongoing development of seladelpar and for working capital and general corporate purposes.

January 30, 2018
·
3 min read
Biotech Bay

Iovance Biotherapeutics Announces Closing of $172.5M Common Stock Public Offering

Iovance intends to use the proceeds from this offering to fund its ongoing clinical trials for its current product candidates, including its ongoing Phase 2 clinical trials of LN-144,

January 30, 2018
·
4 min read
Business

University of Iowa Health Care Increases Industry-Sponsored Clinical Trial Opportunities With TriNetX

In the first six months, UI Health Care was provided access to over 40 clinical trial opportunities from biopharmaceutical companies and CROs on the network.

January 30, 2018
·
3 min read
Business

GW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 5 February, 2018

A replay of the call will also be available through the Company’s website (www.gwpharm.com) shortly after the call.

January 30, 2018
·
1 min read
Business

Dova Pharmaceuticals Announces the Appointment of Mark W. Hahn as CFO

Mark will officially commence in his role as Chief Financial Officer of Dova on January 31st, 2018.

January 30, 2018
·
3 min read
GN Store Nord: Transactions in Relation to Share Buyback Program - Jan. 30, 2018

The share buyback program has been initiated in order to reduce the company’s share capital and to cover obligations under the long-term incentive program.

January 30, 2018
·
2 min read
Business

Suven Revenue up by 11.85%; PAT up by 15.38% for 9 Months Ended December’ 2017

The Un-audited financial results were reviewed by the audit committee and approved by the Board of Directors in their meeting held on 30th Jan’ 2018 at Hyderabad.

January 30, 2018
·
1 min read
Vaxil Completes Oversubscribed Financing to Advance its Cancer Immunotherapy Research and Development

Vaxil Bio is pleased to announce the closing of an oversubscribed equity financing of $1,810,000.

January 30, 2018
·
6 min read